I Manage Medical Supply Purchasing. The Sticker Price Was Never the Real Price.

When I took over purchasing for our health system in 2020, the first significant order I signed off on was a fundus camera for the ophthalmology department. I negotiated the price down 12%. Genuinely thought I’d done well.

Then the follow-up quotes began to land.

An installation fee. A mandatory calibration contract. A software support package that expired after year one. By the time the camera was fully operational, my 12% win was gone—total spend landed 7% above the original quote.

The price? Paid. The cost? We’re still feeling it.

In the five years since, I’ve managed 60–80 medical supply orders per year across hospitals and specialty clinics. I’ve watched the pattern repeat with everything from heart valve replacement inventory to basic ostomy supplies. The price quoted at the start is rarely the price you actually pay. The difference between the two is where budgets go to die.

The deeper problem: devices are sold as products, but they behave like systems

That fundus camera was never just a camera. It was a software platform with a lens attached. The quote covered the hardware. Everything else—the license renewal, the image storage subscription, the “recommended” calibration cycles—arrived as separate conversations. Nobody set out to deceive me. It just wasn’t in the quote.

The same thing happened when our cardiothoracic team requested heart valve replacement stock. Their budget was built around a competitive quote for the valves. What we didn’t know at the time: that quote assumed we already had the specialty instruments, sizing kits, and operating room training. We discovered those line items later.

Then our new ophthalmologist asked us to source intraocular lenses. I had the standard procurement questions ready—volumes, lead times, sterilization compatibility. What I didn’t ask was what happens on the clinical side. Administrators like me don’t usually ask how an IOL is implanted; our surgeons just know. But the delivery system and staff training that implantation requires had real costs attached. A 45-minute required training session came back at $1,800. No purchase order. The invoice arrived after the procedure. I ate the cost.

That’s not a villain story. It’s structural.

Over time I started to recognize that finance and clinical staff speak different languages. I think in P.O.s and budget lines. They think in patient outcomes and procedure schedules. The vendor sits somewhere in between, and the gap between what they quote and what you pay grows in that space.

Three forces keep real pricing hidden

If you ask a vendor “how much does it cost?” you’re asking a question that’s designed to be answered incompletely.

1. Quotes separate what clinical use brings together. Product, software, disposables, training, maintenance—line by line, each piece looks reasonable. The total looks like a problem for later. Later arrives.
2. Clinical urgency does part of the selling. When a surgeon needs something by Friday, procurement isn’t in a position to run competitive bids or pause for third-party cost analysis. Time scarcity works in the vendor’s favor.
3. Context is assumed, and you don’t know what was assumed. Vendors often assume your staff is already trained, your software is compatible, your existing equipment works with theirs. You don’t find out which assumptions were wrong until the first breakdown.

Roughly speaking—and don’t hold me to this figure—I’d estimate that 60–70% of our procurement budget variance in the last five years came from these three factors, not from ordinary price increases.

Hidden costs cost more than money

I have mixed feelings about service fees in medical device contracts. On one hand, they feel like a way to pad margins. On the other hand, I’ve seen the chaos that comes from poorly maintained equipment, so maybe those fees are legitimate. The problem isn’t that fees exist—it’s that they come as a surprise.

In 2022, one supplier couldn’t produce a proper invoice. They sent a handwritten receipt. Finance rejected the expense report—$2,400—and our department absorbed it. That supplier no longer gets our business. Trust disappeared instantly.

There’s also an internal cost that never appears on any line item. When an order shows up late or incomplete, it isn’t just the vendor who looks bad. I answer to the VP. The clinical team answers to patients. A single supply failure can delay a procedure, force a reschedule, and ripple through the schedule for days.

Take this with a grain of salt, because it’s not on any spreadsheet: the trust you lose in one failed order can take a year to rebuild. That’s the real cost of opaque pricing.

What I changed after the 2024 consolidation project

During our 2024 vendor consolidation project, I started asking every supplier a set of transparency questions before I would even look at a price:

• What is NOT included in this quote?
• What does the first year actually cost if every add-on is exercised?
• What training does the clinical staff require, and who provides it?
• What happens when it breaks? Is the response time written into the agreement?
• Can I verify the clinical claims you’re making from an independent source?

I’ve learned to ask “what’s NOT included” before I ask “what does it cost.” The vendor that lists everything upfront—even when the number looks higher—usually costs less by the end.

A surprisingly straightforward example: Coloplast ostomy products

One of the better examples to come out of that vendor consolidation was Coloplast. We were evaluating coloplast products ostomy care for home-care patients. Their quote included the product range—including the SenSura Mio line we ultimately chose—the accessories that needed periodic replacement, scheduled delivery timelines, and nurse training as a line item with actual numbers. Every significant cost was on the page.

What impressed me even more was the clinical verification piece. We looked up coloplast clinical trial news to validate their claims. Their studies appear on ClinicalTrials.gov under the sponsor name Coloplast A/S. For a non-clinical buyer like me, being able to independently look at endpoints and patient-reported outcomes without relying on a sales presentation made a significant difference.

We chose them. And I won’t pretend the decision was free of doubt. Even after finalizing the contract, I kept second-guessing. What if the reliability we saw during the pitch didn’t hold up under everyday pressure? I didn’t fully relax until the first three deliveries arrived on schedule and the invoices matched the quotes to the cent.

They have. Consistently.

I’m not claiming that the transparent vendor is always the cheapest. Often it isn’t. But it’s the option that lets a purchasing manager plan, budget, and sleep at night. It saves the cost of explaining mysterious charges to your finance committee. And when you buy medical equipment for a living, that’s worth more than any 12% discount.

Because at the end of the year, the invoice tells the truth about which vendor was really the most expensive.